Skip to content

Lead triggers hepatocyte ferroptosis through coordinated mitochondrial injury and ER stress-mediated autophagic degradation of GPX4.

Aug 2026 · Toxicology · pp. 154567 · 0 citations · 68 references
Medicine

TL;DR

The findings reveal a novel hierarchical cascade, mitochondrial ROS-driven ER stress leading to autophagic degradation of GPX4, as a core mechanism of Pb-induced hepatic ferroptosis, and TUDCA was identified as a potential therapeutic agent for Pb-induced hepatotoxicity.

Abstract

Lead (Pb) is one of the major heavy metal pollutants that induces multi-organ toxicity. Liver is the primary target of Pb, the exposure of which induces hepatotoxicity by triggering hepatocyte cell death. Ferroptosis, a novel iron-dependent form of regulated cell death, has recently been implicated in a variety of heavy metal-induced organ injuries. In this study, we have identified that ferroptosis is involved in acute Pb exposure-induced liver injury. Our results showed that Pb (1mM) induced ferroptosis in Hepa1-6 cells, as evidenced by the increase of intracellular ferrous levels and lipid peroxidation. Ferrostatin-1 (Fer-1, 20μM), a ferroptosis inhibitor, alleviated the hepatocyte cell death. Mechanistically, Pb impaired mitochondria and promoted mitochondrial superoxide production. The mitochondrial reactive oxygen species (ROS) subsequently led to lipid peroxidation, and activated endoplasmic reticulum (ER) stress, which in turn promoted autophagy. The induced-autophagy facilitated the degradation of GPX4 and contributed to the destabilization of SLC7A11. MitoTEMPO (200μM), a mitochondria-targeted antioxidant, effectively attenuated Pb-induced ferroptosis by reducing lipid peroxidation, relieving ER stress, and stabilizing SLC7A11 and GPX4. Furthermore, tauroursodeoxycholic acid (TUDCA, 800μM in vitro and 150mg/kg in vivo), a chemical chaperone, protected against Pb-induced hepatocyte ferroptosis and liver injury by preserving mitochondrial integrity, suppressing ER stress dependent autophagy, and restoring SLC7A11 and GPX4 expression. Our results indicated that mitochondrial ROS may serve as the upstream trigger of Pb-induced ferroptosis, not only facilitating lipid peroxidation, but also impairing the antioxidant defense system. Collectively, our findings reveal a novel hierarchical cascade, mitochondrial ROS-driven ER stress leading to autophagic degradation of GPX4, as a core mechanism of Pb-induced hepatic ferroptosis. Furthermore, TUDCA was identified as a potential therapeutic agent for Pb-induced hepatotoxicity.

View source

Similar papers

Review Aug 2026

Programmed cell death in kidney disease: integrated crosstalk among ferroptosis, pyroptosis, apoptosis, and cuproptosis

A “metabolic crisis-cascade” framework is proposed, in which progressive disruption of energy metabolism, redox balance, and metal homeostasis acts as a unifying upstream mechanism linking multiple PCD pathways during kidney injury and preventing AKI-to-CKD transition.

Jiajun Sang, Zhen-Tao Guo, Cheng-Xia Kan et al. · 2 citations
Oct 2026

Targeting activated hepatic stellate cells through ferroptosis: phenethyl isothiocyanate attenuates CCl4-induced liver fibrosis by regulating iron metabolism, redox homeostasis, and autophagy.

It is shown that PEITC alleviates liver fibrosis by promoting ferroptosis-related processes in activated HSCs, mainly through the NCOA4/FTH1 axis, positioning it as a promising nutraceutical candidate for antifibrotic therapy.

Meng-Xue Sun, Jia-Xin Qin, Yuan-Fen Xie et al. · 0 citations
Review Open access Aug 2026

Harnessing autophagy-dependent ferroptosis: Mechanisms and therapeutic opportunities in human diseases.

A target-cell-oriented pharmacological map that integrates their autophagic targets, ferroptotic effects, disease contexts and relevant target-cell populations is constructed, thereby providing a rationale for developing ADF-based therapeutic strategies with defined indications, measurable pharmacodynamic biomarkers an...

Xiao Cui, Xinzhu Dong, Yang Li et al. · 0 citations
Open access Sep 2026

MFN1 Mediates Doxorubicin-Induced Cytotoxicity through Oxidative Stress-Induced Ferroptosis

DOX-induced cardiotoxicity reveals MFN1 as a key regulatory factor in DIC and provides a novel theoretical basis for its potential as a therapeutic target and inhibition of MFN1 significantly alleviates DIC injury.

J. Gao, M. Xue, Y. Zhangsun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.